Fig. 5.
Effects of R9-CMV on T and B cell apoptosis in patients with chronic HCV infection (n = 30) and healthy donors (n = 15). Data are expressed as percentage of apoptotic CD3+ or CD19+ lymphocytes (mean±SD) after 3 days of cell culture in the absence or presence of R9-CMV as stimulant. Significance of HCV versus HD: **p < 0.02; significance of R9-CMV versus homologous NS cells: @ p < 0.005; & p < 0.001